TALi
TALi is a small business in the Health, Wellness & Fitness industry, founded in 2014 and headquartered in Cremorne, Victoria, AU. The company specializes in digital therapeutics and diagnostics, focusing on non-invasive early interventions for cognitive skills, particularly in ADHD and ASD.
Company Overview
TALi, founded in 2014, operates in the Health, Wellness & Fitness industry with a focus on digital therapeutics and diagnostics. The company is headquartered in Cremorne, Victoria, Australia, and employs a team of 40 individuals. TALi specializes in creating personalized experiences aimed at enhancing cognitive function through evidence-based, video-game solutions. The company is recognized as a small business and is listed on the Australian Securities Exchange (ASX) under the ticker code TD1.
Products and Services
TALi has developed two primary programs: TALi DETECT® and TALi TRAIN®. DETECT® serves as a screening tool, while TRAIN® is a training program designed for children aged 3 to 10 years. Both programs target cognitive attention skills and are based on video-game technology. The ReadyAttentionGo app, available on Android and iOS, supports these initiatives. The programs have demonstrated efficacy in improving attention and numeracy skills and reducing impulsive behavior, with 95% of children reported by parents to maintain or improve attention skills.
Research and Development
TALi engages in a core research program that explores applications for populations with Mild Cognitive Decline, a precursor to Alzheimer’s disease and other forms of dementia. The company's research and development activities are led by a team of scientists and clinicians, ensuring a robust evidence-based approach. TALi's products have been validated through gold-standard randomized controlled trials, demonstrating their effectiveness in cognitive training.
Market Strategy and Partnerships
TALi employs a multi-layered strategy to reach customers across global markets, including marketing campaigns initiated in India and refreshed plans for Australia, New Zealand, and Singapore. The company has established a landmark agreement with Akili Interactive Labs to open the prescription healthcare channel in the United States. Additionally, TALi is an official Google for Education Partner and is registered as an NDIS Provider.
Financial Overview
TALi does not currently pay dividends, as funds are reinvested into product commercialization. The company reports financial results biannually in February and August, with quarterly updates in January, April, July, and October. TALi has approximately four quarters of cash available to fund its operations and commercialization strategy, reflecting a commitment to sustainable growth.